Friday, August 28, 2026
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk Reuters FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes Eli Lilly and Company Lilly Diabetes Shot Mounjaro Wins US Approval for Heart Disease Bloomberg.com Lill
When you are ready to buy with escrow protection and NFC verification, browse the official-brand catalog. LAIZ Shop lists official brands only — no grey-market listings.
Shop the story
Verified picks related to this topic
